Finance

Lists
Q2 2026 earnings • released • EPS miss -1.66% • Revenue beat +1.72%
See results
6446:TPE
PharmaEssentia Corp
NT$1,445.00
0.00%
(0.00) 1D
Aug 13, 1:30:20 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Mkt. cap
610.42B
Avg. vol.
3.58M
Volume
0.00
Dividend
0.09%
Quarterly dividend
NT$0.34
Ex-dividend date
Aug 11, 2025
P/E ratio
100.34
52-wk high
NT$1,550.00
52-wk low
NT$397.24
EPS
NT$14.40
No. of employees
131
Mkt. cap
610.42B
Avg. vol.
3.58M
Volume
0.00
Dividend
0.09%
Quarterly dividend
NT$0.34
Ex-dividend date
Aug 11, 2025
P/E ratio
100.34
52-wk high
NT$1,550.00
52-wk low
NT$397.24
EPS
NT$14.40
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
FoundedMay 9, 1990
Headquarters-
SectorBiotechnology
Websitepharmaessentia.com
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (TWD)
NT$6.13 / NT$6.23
-1.66%miss
Revenue / Est. (TWD)
6.86B / 6.74B
+1.72%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.60B
3.89B
4.88B
5.12B
Cost of goods sold
450.20M
327.93M
543.68M
621.28M
Cost of revenue
450.20M
327.93M
543.68M
621.28M
Research and development expenses
828.53M
884.63M
1.01B
857.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.23B
1.52B
1.77B
1.56B
Operating expense
2.06B
2.40B
2.78B
2.41B
Total operating expenses
2.51B
2.73B
3.32B
3.03B
Operating income
1.10B
1.17B
1.56B
2.09B
Other non operating income
4.48M
238.00K
4.37M
1.32M
EBT including unusual items
95.82M
1.41B
2.01B
2.34B
EBT excluding unusual items
95.82M
1.41B
2.01B
2.34B
Income tax expense
-736.43M
-59.18M
536.45M
185.95M
Effective tax rate
-768.54%
-4.19%
26.65%
7.96%
Other operating expenses
-
-
-
-
Net income
832.25M
1.47B
1.48B
2.15B
Net profit margin
23.10%
37.83%
30.24%
41.97%
Earnings per share
2.02
3.60
3.58
5.21
Interest and investment income
175.57M
123.73M
142.46M
139.53M
Interest expense
-8.83M
-5.55M
-5.76M
-4.71M
Net interest expenses
166.75M
118.18M
136.70M
134.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.13B
1.20B
1.60B
2.14B
Gain or loss from assets sale
-
-
1.50M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps